Literature DB >> 205875

Chimeric mice derived from human-mouse hybrid cells.

K Illmensee, P C Hoppe, C M Croce.   

Abstract

Mouse teratocarcinoma cells from the OTT6050 ascites tumor were established in tissue culture and selected for 5-bromodeoxyuridine (BrdUrd) resistance. The embryonal carcinoma cells grew without a feeder layer, remained deficient for thymidine kinase (EC 2.7.1.75), and differentiated like the original tumor into various tissues after subcutaneous injection into 129 mice. We fused the BrdUrd-resistant mouse teratocarcinoma cells with HT1080-6TG human diploid fibrosarcoma cells deficient in hypoxanthine phosphoribosyltransferase (EC 2.4.2.8) and selected for hybrid cells in hypoxanthine/aminopterin/thymidine medium. The resulting hybrid cells segregated human chromosomes quickly and retained one to three human chromosomes including chromosome 17 that carries the human genes for thymidine kinase and galactokinase (EC 2.7.1.6). Single hybrid cells from five independent clones containing human chromosome 17 were injected into mouse blastocysts bearing several genetic markers that affect the coat color phenotype and strain-specific enzyme variants in order to detect tissue differentiation derived from the injected cells. After the injection of single hybrid cells into a total of 103 experimental blastocysts that had been surgically transferred to pseudopregnant foster mothers, 49 mice were born and 2 of them clearly revealed coat mosaicism. In 2 of 17 mice thus far analyzed, the injected hybrid cells proved to be capable of participating substantially in development of seven different organs. However, human gene products have not yet been detected unequivocally in those tissues and weak human-specific galactokinase activity could be recovered only from two mosaic tissues. Our results demonstrate that, after in vitro culture and selection, at least some of the human-mouse hybrid cells still retain their in vivo potential to differentiate and become functionally integrated in the living organism. It now seems feasible to cycle mouse teratocarcinoma cells carrying human genetic material through mice via blastocyst injection to study human gene expression during differentiation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 205875      PMCID: PMC392452          DOI: 10.1073/pnas.75.4.1914

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Fate of teratocarcinoma cells injected into early mouse embryos.

Authors:  V E Papaioannou; M W McBurney; R L Gardner; M J Evans
Journal:  Nature       Date:  1975-11-06       Impact factor: 49.962

2.  SELECTION OF HYBRIDS FROM MATINGS OF FIBROBLASTS IN VITRO AND THEIR PRESUMED RECOMBINANTS.

Authors:  J W LITTLEFIELD
Journal:  Science       Date:  1964-08-14       Impact factor: 47.728

3.  MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS.

Authors:  L J KLEINSMITH; G B PIERCE
Journal:  Cancer Res       Date:  1964-10       Impact factor: 12.701

4.  Loss of mouse chromosomes in somatic cell hybrids between HT-1080 human fibrosarcoma cells and mouse peritioneal macrophages.

Authors:  C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

5.  Ovarian teratomas in mice are derived from oocytes that have completed the first meiotic division.

Authors:  J J Eppig; L P Kozak; E M Eicher; L C Stevens
Journal:  Nature       Date:  1977-10-06       Impact factor: 49.962

6.  Effect of environmental pH on the efficiency of cellular hybridization.

Authors:  C M Croce; H Koprowski; H Eagle
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

7.  A rapid banding technique for human chromosomes.

Authors:  M Seabright
Journal:  Lancet       Date:  1971-10-30       Impact factor: 79.321

8.  Linkage relationship between the genes for thymidine kinase and galactokinase in different primates.

Authors:  K G Orkwiszewski; T A Tedesco; W J Mellman; C M Croce
Journal:  Somatic Cell Genet       Date:  1976-01

9.  Mosaic mice with teratocarcinoma-derived mutant cells deficient in hypoxanthine phosphoribosyltransferase.

Authors:  M J Dewey; D W Martin; G R Martin; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts.

Authors:  K Illmensee; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

View more
  12 in total

1.  Transgenesis by means of blastocyst-derived embryonic stem cell lines.

Authors:  A Gossler; T Doetschman; R Korn; E Serfling; R Kemler
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

2.  Xenogeneic gene expression in chimeric mice derived from rat--mouse hybrid cells.

Authors:  K Illmensee; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

3.  A compendium of the mouse mammary tumor biologist: from the initial observations in the house mouse to the development of genetically engineered mice.

Authors:  Robert D Cardiff; Nicholas Kenney
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-06-01       Impact factor: 10.005

4.  [Teratoma and the mammalian embryo].

Authors:  K Illmensee
Journal:  Naturwissenschaften       Date:  1986-08

5.  Introduction of a human X-6 translocation chromosome into a mouse teratocarcinoma: investigation of control of HLA-A, B, C expression.

Authors:  P N Goodfellow; G Banting; J Trowsdale; S Chambers; E Solomon
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

6.  Does the major histocompatibility complex serve as a specific receptor for Semliki Forest virus?

Authors:  M B Oldstone; A Tishon; F J Dutko; S I Kennedy; J J Holland; P W Lampert
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

7.  Monozygotic vs. dizygotic twin behavior in artificial mouse twins.

Authors:  E Baunack; U Falk; K Gärtner
Journal:  Genetics       Date:  1984-03       Impact factor: 4.562

8.  Differentiation in vitro of human-mouse teratocarcinoma hybrids.

Authors:  F J Benham; M V Wiles; P N Goodfellow
Journal:  Mol Cell Biol       Date:  1983-12       Impact factor: 4.272

9.  Deoxyribonuclease I sensitivity of plasmid genomes in teratocarcinoma-derived stem and differentiated cells.

Authors:  K Huebner; A Linnenbach; S Weidner; G Glenn; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

10.  Genetic transformation of mouse embryos by microinjection of purified DNA.

Authors:  J W Gordon; G A Scangos; D J Plotkin; J A Barbosa; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.